Antihyperlipidemic Agents. Hyperlipidemia  Hyperlipidemia is the most prevalent indicator for susceptibility to atherosclerotic heart disease.  it is.

Slides:



Advertisements
Similar presentations
Agents Used in the Treatment of Hyperlipidemia
Advertisements

Atherosclerosis Focal plaques within the intima containing cholesterol and cholesterol esters (CE) Affects large and medium sized arteries Causes coronary.
Cholesterol and Bile Acid Metabolism
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Drugs and Dyslipidemias (statins and other lipid and atherosclerosis-modifying drugs) October 18, 2006 Frank F. Vincenzi.
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
Treatment of Dyslipidemia SDPI CGP Healthy Heart Project March 8, 2006.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 50 Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol.
Lipoprotein management in Patients With Cardiometabolic Risk Consensus conference report JACC April 2008 Sandra Rodriguez, M.D. Internal Medicine.
Anti-Hypercholesterolemic Agents  Biosynthesis and Metabolism of Cholesterol  What is arteriosclerosis? - Link between arteriosclerosis and cholesterol.
ANTILIPEMICS LILLEY, READING & WORKBOOK: CHAP 28 Cardiovascular System.
Pharmacology of Agents Used in Hyperlipidemia
HYPERLIPIDEMIAS  Conditions in which the concentrations of cholesterol or triglyceride carrying lipoproteins exceed arbitrary normal limits.
Antiatherosclerosis drugs. Lipid-regulating drugs  Background  Lipoprotein  Classification of Lipoprotein: CM 、 VLDL 、 IDL 、 LDL 、 HDL 、 Lp(a) CM 、
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 29 Antilipemic Drugs.
Drug Treatment of Hyperlipidemia
The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Kirk Mykytyn, Ph.D. Department of Pharmacology
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
Medicinal Chemistry II 313 PHC
Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.
Antidislipidemic drugs ( Summary ) © Dr Ivan Lambev, PhD Medical University of Sofia, Faculty of Medicine Department.
ANTIHYPERLIPIDEMIC DRUGS
Drug Treatment of Hyperlipidemia Philip Marcus, MD.
Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.
Antihyperlipidemia.
Arteriosclerosis= hardening of the arteries.. ↑Serum cholesterol (above 4mmol/L)  ↑risk of coronary heart disease
Hyperlipoprotinemias Department of Pharmacology College of Medicine.
Management & Medications  Diet, weight loss and drug therapy are the mainstay of treatment, while exercise training is used as adjunctive therapy  Lipid-lowering.
Antihyperlipidemic drugs The clinically important lipoproteins are LDL low density lipoprotein, VLDL very low density lipoprotein, HDL high density lipoprotein.
Part 5 Antiatheroscleotic drugs. §Plasma lipids § Cholesterol free cholesterol (FC) § cholesterolester (CE) § Triglyceride (TG) § Phospholipid (PL)
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Jiří Slíva, M.D. statins (inhibitors of HMG-CoA reductase) fibrates anion - exchange resins nicotinic acid group.
Hypolipidemic Drugs and plasma expanders
HYPERLIPIDEMIA Applied Therapeutics Dr. Riyadh Mustafa Al-Salih.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Antilipemic Drugs.
Hypolipidemic Drugs.
HLD Tx & AHA/ACC Guidelines
Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.
Management of Hyperlipoprotinaemia
1 HYPOLIPIDAEMICS or LIPID LOWERING DRUGS. 2 Hypolipidaemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Cholesterol Metabolism.  The chemical and biochemical aspects of cholesterol regarding structure, distribution and biological functions in human body.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
50 Drugs that Help Normalize Cholesterol & Triglyceride Levels
Overview Lipoprotein metabolism Digestive lipid metabolism
Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.
Drugs Used in Hyperlipidemia
Agents used in Hyperlipidemia. Objectives: To review the proposed role of lipoprotein in the formation of atherosclerotic plaques. To study various types.
Antihyperlipidemic Drugs
Cholesterol metabolism
Hyperlipidemias.
أبدا لم يفت الاوان لكي تبدأ
Drugs for Lipid Disorders
Anti-Hypercholesterolemic Agents
By: Dr Israa Omar MBBS, MRCP, MSc pharmacology
Formative Test.
Anti-Hypercholesterolemic Agents
Biosynthesis and Metabolism of Cholesterol
Antilipidaemic agents
Antihyperlipidemic Drugs
Cardiovascular System
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Drugs for Hyperlipidemia
Lipoproteins   Macromolecular complexes in the blood that transport lipids Apolipoproteins   Proteins on the surface of lipoproteins; they play critical.
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Presentation transcript:

Antihyperlipidemic Agents

Hyperlipidemia  Hyperlipidemia is the most prevalent indicator for susceptibility to atherosclerotic heart disease.  it is a term used to describe elevated plasma levels of lipids that are usually in the form of lipoproteins.

Lipoproteins Metabolism

Lipid-lowering drugs can be classified into:  Sequestering agents (Bile acids sequestrants)  Inhibitor of de novo cholesterol biosynthesis. (HMG-CoA Reductase inhibitors)  Alteration of cholesterol metabolism  Inhibition of lipoprotein synthesis.  Miscellaneous.

1-Sequestering agents (Bile acids sequestrants)

Cholestyramine Resin (Questran)  It is a styrene copolymer with divinylbenzene with quaternary ammonium functional groups.

Colestipol HCl (Colestid)  It is a high-molecular-weight, insoluble, granular copolymer.  It reduces cholesterol levels without affecting triglycerides.

Colesevelam (Welchol)  It does not possess Cl- ion (as in Cholestyramine and colestipol) and is not an anion-exchange resin.

2-Inhibitor of de novo cholesterol biosynthesis (HMG-CoA Reductase inhibitors).

Lovastatin (Mevacor)  It is a potent inhibitor of HMG-CoA reductase.  For inhibitory effect on HMG-CoA reductase, the lactone ring must be hydrolyzed to the open-ring heptanoic acid

Simevastatin (Zocor)  It is an analogue of Lovastatin.

3-Alteration of cholesterol metabolism

Dextrothyroxine sodium (Choloxin) O-(4-Hydroxy-3,5-diiodsophenyl)-3,5-diiodo-D- tyrosine monosodium hydrate.

Clofibrate (Atromid-S) Ethyl 2-(p-chlorophenoxy)-2-methylpropionate

Clofibrate is prepared by Williamson synthesis.

Gemfibrozil (Lopid) 5-(2,5-Dimethylphenoxy)-2,2-dimethyl pentanoic acid  It is structurally similar to clofibrate.  Its mechanism of action and use are similar to those of clofibrate.

Finofibrate (Tricor) 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1- methylethyl ester.  It has structural features represented in clofibrate.

Structure-activity relationship of fibrates

4-Inhibition of lipoprotein synthesis.

Probucol (Lorelco) 4,4-[(1-Methylethyliden)-bis thio-[2,6-bis(1,1- dimethyethyl)] phenol.  Probucol has high lipophilic characters with strong antioxidant properties.

Nicotinic acid, Niacin 3-Pyridine carboxylic acid.  It has the ability to inhibit lipolysis (i.e. prevent the release of free fatty acids and glycerol from fatty tissues).

Pentaerthritol tetranicotinate  Pentaerthritol tetranicotinate is an example of molecular association in which a tetra- replicate of nicotinic acid was developed (Molecular replication).

5-Miscellaneous.

β-Sitosterol  Sitosterol is a plant sterol, whose structure is identical with that of cholesterol, except for the substituted ethyl group on C-24 of its side chain.  The drug inhibits the absorption of dietary cholesterol from the gastrointestinal tact.